States and substance abuse treatment programs: Funding and guidelines for infection-related services

American Journal of Public Health

Volumn 98, Issue 5, 2008, Pages 824-826

  Kritz, Steven ^a   Brown Jr , Lawrence S ^a,b   Goldsmith, R Jeffrey ^c   Bini, Edmund J ^d,e   Robinson, Jim ^f   Alderson, Donald ^g   Novo, Patricia ^d,e   Rotrosen, John ^d,e  

^a Addiction Research and Treatment Corporation   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^g New York University School of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; SEXUALLY TRANSMITTED DISEASE; SUBSTANCE ABUSE; ADDICTION; CLINICAL TRIAL; COMMUNICABLE DISEASE; COMMUNITY CARE; ECONOMICS; HEALTH CARE PLANNING; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; UNITED STATES;

CLINICAL TRIALS AS TOPIC; COMMUNICABLE DISEASES; COMMUNITY HEALTH SERVICES; GUIDELINES AS TOPIC; HEALTH POLICY; HEPATITIS C; HIV INFECTIONS; HUMANS; SEXUALLY TRANSMITTED DISEASES; STATE HEALTH PLANS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 43049164349     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2007.119578     Document Type: Article

References (18)

1. Booth RE, Watters JK, Chitwood DD. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health. 1993;83:1144-1147.
2. Francis H. Substance abuse and HIV infection. Top HIV Med. 2003;11:20-24.
3. Zylberberg H, Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clin Infect Dis. 1996;23:1117-1125.
4. Lorvick J, Kral AH, Seal K, Gee L, Edlin BR. Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health. 2001;91:46-47.
5. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore). 1995;74:212-220.
6. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J AIDS. 1998;18(suppl 1):S11-S19.
7. Belongia EA, Danilia RN, Angamuthu V, et al. A population-based study of sexually transmitted disease incidence and risk factors in human immunodeficiency virus-infected people. Sex Transm Dis. 1997;24:251-256.
8. Fortenberry JD, Brizendine EJ, Katz BP, Wools KK, Blythe MJ, Orr DP. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex Transm Dis. 1999;26:26-32.
9. Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE. Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis. 2005;32:446-453.
10. Battjes RJ, Pickens RW, Brown LS Jr. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:90-96.
11. Broers B, Junet C, Bourquin M, Deglon JJ, Perrin L, Hirschel B. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS. 1998;12:2059-2066.
12. Poulin C, Alary M, Bernier F, Ringuet J, Joly JR. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and HIV infection among drug users attending an STD/HIV prevention and needle-exchange program in Quebec City, Canada. Sex Transm Dis. 1999;26:410-420.
13. Bachmann LH, Lewis I, Allen R, et al. Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility. Am J Public Health. 2000;90:1615-1618.
14. Edlin BR, Kresina TF, Raymond DB, et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis. 2005;40(suppl 5):276-285.
15. Farrell M, Gowing L, Marsden J, Ling W, Ali R. Effectiveness of drug dependence treatment in HIV prevention. Int J Drug Policy. 2005;16(supp1):67-75.
16. Brown LS, Kritz S, Goldsmith RJ, et al. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2006;30:315-321.
17. Brown LS, Kritz S, Goldsmith RJ, et al. Health services for HIV/AIDS, hepatitis C virus, and sexually transmitted infections in substance abuse treatment programs. Public Health Rep. 2007;122:441-451.
18. Report on the Center for Substance Abuse Treatment Human Immunodeficiency Virus Survey of Single State Authorities. Washington, DC: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration; 2000:Table II-2.